Corporate Announcement
Security Code : 530019    Company : JUBLPHARMA    
 
Announces Q2 results (Standalone & Consolidated), Results Press Release, Presentation & Limited Review Report (Standalone & Consolidated) for the Quarter ended September 30, 2016Download PDF
  Exchange Disseminated Time     27/10/2016 15:34:19
Jubilant Life Sciences Ltd has announced the following results for the quarter ended September 30, 2016:

The Unaudited Standalone results for the Quarter ended September 30, 2016

The Company has posted a net profit of Rs. 241.20 million for the quarter ended September 30, 2016 as compared to Rs. 516.10 million for the quarter ended September 30, 2015. Total Income has decreased from Rs. 7840.30 million for the quarter ended September 30, 2015 to Rs. 6302.70 million for the quarter ended September 30, 2016.

The Consolidated Results are as follows:

The Unaudited Consolidated results for the Quarter ended September 30, 2016

The Group has posted a net profit after taxes, minority interest & share of profit / loss of associates of Rs. 1447.70 million for the quarter ended September 30, 2016 as compared to Rs. 1264.20 million for the quarter ended September 30, 2015. Total Income has decreased from Rs. 14963.90 million for the quarter ended September 30, 2015 to Rs. 14242.60 million for the quarter ended September 30, 2016.
 

Disclaimer

Back To Announcements